IGFBP2 was correlated with M2 Macrophages, CD8+ T cells, which enhanced the immunosuppression of glioblastoma and it might be an effective immunotherapeutic strategy for glioblastoma therapy (38); However, there are no similar reports relating to IGFBP2 and DCs. This evidence concerns the gene CD8A and glioblastoma.